Vascular Division News
Dr. Amit Dwivedi, Associate Professor, Division of Vascular Surgery and Endovascular Therapeutics, has been named Chief of the Division of Vascular Surgery and Endovascular Therapeutics. Dr. Dwivedi was recruited to the Department of Surgery following fellowship training in vascular surgery at Long Island Jewish Medical Center, New York and joined the faculty in vascular surgery in 2007. Dr. Dwivedis clinical interests include diseases of the thoracic aorta (TEVAR), hemodialysis access, continuous study of the roles of open, hybrid, and minimally invasive endovascular therapies in relation to cost and outcome.
Dr. Andrea Yancey, Assistant Professor of Surgery, Division of Vascular Surgery and Endovascular Therapeutics, was profiled in the Courier-Journal about her volunteer work in Landstuhl, Germany helping treat wounded military men and women out of combat in Iraq and Afghanistan. To read to story, go to: www.courier-journal.com.
On May 18, UofLs Omar Hamdallah, MD matched in the Vascular Residency program at Long Island Jewish Medical Center and Abindra Sigdel matched in the Vascular Residency program at Methodist in Houston.
On February 11, 2011 Dr. Marvin E. Morris, an Instructor within the Division of Vascular Surgery and Endovascular Therapeutics, received intramural funding from the UofL School of Medicine Basic Grant Program to further utilize the novel approach of invitro blood vessel mimics (BVM) to elucidate and inhibit neointimal hyperplasia. Neointimal hyperplasia is a dynamic and challenging clinical problem with no clear therapeutic intervention. The ultimate goal of Dr. Morris and his research team at the Cardiovascular Innovations Institute (CII) is to identify a locally delivered, clinically useful therapeutic entity to inhibit this process.
The Division of Vascular Surgery and Cardiovascular Innovation Institute (CII) held the inaugural Vascular Biology Symposium Feb. 17, 2011 at CII. Visiting professors Drs. Colleen Brophy and Raul Guzman from Vanderbilt participated.